FDA
approval
· 2024-08-28
FDA Approved: DIHYDROERGOTAMINE MESYLATE — Supplemental Application (Provepharm Inc.)
Summary
FDA approved a supplemental application for dihydroergotamine mesylate from Provepharm Inc. under ANDA212046.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for DIHYDROERGOTAMINE MESYLATE (DIHYDROERGOTAMINE MESYLATE)